GE Healthcare has inked an agreement to acquire the assets of Orbotech Medical Solutions, the manufacturer of cadmium zinc telluride (CZT) detectors used in its Alcyone nuclear medicine technology.
The Chalfont St. Giles, U.K.-based vendor will pay $9 million in cash at closing and up to an additional $5 million in cash for the Yavne, Israel-based firm, subject to the achievement of performance-based milestones.
The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close by the first quarter of 2011, GE said.
Related Reading
GE, UPMC test digital pathology, October 28, 2010
GE preps upgrades for ICD-10 codes, October 26, 2010
GE debuts follicle ultrasound software, October 25, 2010
GE to buy Clarient for $580M, October 22, 2010
Court grants Orbotech motion in GE suit, July 7, 2009
Copyright © 2010 AuntMinnie.com
